circRNA hsa_circ_0001819抑制铁死亡并促进结直肠癌细胞恶性表型的作用及潜在机制OA
Role and potential mechanism of circRNA hsa_circ_0001819 in suppressing ferroptosis and promoting malignant phenotypes in colorectal cancer cells
背景与目的:铁死亡是一种以铁依赖性脂质过氧化为特征的调节性细胞死亡方式,在结直肠癌(CRC)治疗中具有潜在应用价值.环状RNA(circRNA)可通过竞争性内源性RNA(ceRNA)机制参与肿瘤发生发展,但其在 CRC 铁死亡中的作用及调控机制尚不明确.本研究旨在筛选 CRC 中异常表达的circRNA,探讨hsa_circ_0001819(circ1819)对CRC细胞铁死亡及恶性生物学行为的影响,并初步分析其潜在分子机制. 方法:整合分析 GSE223001 和 GSE205643 circRNA 微阵列数据集,并利用 GSE126094 进行验证,筛选CRC中差异表达的circRNA.采用qRT-PCR检测circ1819在CRC组织及细胞中的表达,并通过RNase R消化、放线菌素 D 处理及核质分离实验验证其环状结构、稳定性和亚细胞定位.采用 siRNA 敲低circ1819,结合铁死亡诱导剂(RSL3)及铁死亡抑制剂(Lip-1),通过细胞活力、脂质活性氧(ROS)、丙二醛(MDA)及铁死亡相关蛋白检测评价其对CRC细胞铁死亡的影响;采用CCK-8、平板克隆形成及Transwell实验评价其对CRC细胞增殖和迁移的影响.通过AGO2-RNA结合蛋白免疫沉淀(AGO2-RIP)、RNA pulldown实验及生物信息学分析探讨circ1819潜在的ceRNA调控关系. 结 果:circ1819在CRC组织和细胞中显著高表达,其表达水平与肿瘤直径及T分期相关.circ1819具有典型的circRNA特征,主要定位于细胞质.敲低circ1819可显著增强CRC细胞对RSL3诱导的铁死亡敏感性,表现为细胞活力降低、脂质ROS和MDA水平升高,该效应可被Lip-1部分逆转.circ1819敲低后GPX4的mRNA及蛋白表达显著降低,而SLC7A11和ACSL4表达无明显变化.同时,敲低circ1819可显著抑制CRC细胞增殖、克隆形成及迁移能力.AGO2-RIP和RNA pulldown实验提示circ1819可与miR-618和miR-1231发生相互作用;进一步结合靶基因预测及富集分析,构建了以circ1819为核心的circRNA-miRNA-mRNA潜在调控网络. 结 论:circ1819在CRC中异常高表达,敲低circ1819可增强CRC细胞铁死亡敏感性并抑制其增殖和迁移,其作用可能与miR-618和miR-1231介导的ceRNA调控及GPX4表达变化有关.circ1819可能是连接CRC恶性进展与铁死亡抵抗的潜在调控分子,但其具体下游靶基因及因果调控关系仍需进一步验证.
Background and Aims:Ferroptosis is an iron-dependent form of regulated cell death characterized by lipid peroxidation and has potential applications in colorectal cancer(CRC)therapy.Circular RNAs(circRNAs)can regulate tumor progression through competing endogenous RNA(ceRNA)mechanisms;however,their roles and regulatory mechanisms in CRC ferroptosis remain incompletely understood.This study aimed to identify dysregulated circRNAs in CRC,investigate the effects of hsa_circ_0001819(circ1819)on ferroptosis and malignant phenotypes of CRC cells,and preliminarily explore its potential molecular mechanism. Methods:CircRNA microarray datasets GSE223001 and GSE205643 were integrated to identify differentially expressed circRNAs,with GSE126094 used for validation.The expression of circ1819 in CRC tissues and cell lines was examined by qRT-PCR.RNase R digestion,actinomycin D treatment,and nuclear-cytoplasmic fractionation assays were performed to characterize its circular structure,stability,and subcellular localization.Following siRNA-mediated circ1819 knockdown,cell viability,lipid reactive oxygen species(ROS),malondialdehyde(MDA),and ferroptosis-related proteins were assessed in the presence of the ferroptosis inducer RSL3 and inhibitor Liproxstatin-1(Lip-1).CCK-8,colony formation,and Transwell assays were used to evaluate cell proliferation and migration.AGO2 RNA immunoprecipitation(AGO2-RIP),RNA pulldown,and bioinformatics analyses were performed to investigate the potential ceRNA regulatory mechanism of circ1819. Results:Circ1819 was significantly upregulated in CRC tissues and cell lines,and its expression was associated with tumor diameter and T stage.Circ1819 exhibited typical characteristics of a circular RNA and was predominantly localized in the cytoplasm.Circ1819 knockdown significantly increased the sensitivity of CRC cells to RSL3-induced ferroptosis,as evidenced by reduced cell viability and increased lipid ROS and MDA levels;these effects were partially reversed by Lip-1.Circ1819 knockdown significantly reduced GPX4 mRNA and protein expression,whereas SLC7A11 and ACSL4 expression remained unchanged.Moreover,circ1819 knockdown significantly inhibited CRC cell proliferation,colony formation,and migration.AGO2-RIP and RNA pulldown assays suggested interactions between circ1819 and miR-618 or miR-1231.Combined with target prediction and enrichment analyses,a potential circ1819-centered circRNA-miRNA-mRNA regulatory network was constructed. Conclusion:Circ1819 is aberrantly upregulated in CRC,and its knockdown enhances ferroptosis sensitivity while suppressing proliferation and migration of CRC cells.These effects may be associated with ceRNA regulation involving miR-618 and miR-1231 and alterations in GPX4 expression.Circ1819 may represent a potential regulatory link between malignant progression and ferroptosis resistance in CRC,although its downstream targets and causal regulatory relationships require further validation.
龙飞;梁妮;郑勋日;叶永鑫;陈淼
中南大学湘雅三医院 胃肠外科,湖南 长沙 410013||中南大学湘雅三医院 基础医学博士后流动站,湖南 长沙 410013中南大学湘雅三医院 血液内科,湖南 长沙 410013中南大学湘雅三医院 胃肠外科,湖南 长沙 410013中南大学湘雅三医院 胃肠外科,湖南 长沙 410013中南大学湘雅三医院 胃肠外科,湖南 长沙 410013
医药卫生
结直肠肿瘤RNA,环状RNA,竞争性内源性微RNAs铁死亡
Colorectal NeoplasmsRNA,CircularRNA,Competitive EndogenousMicroRNAsFerroptosis
《中国普通外科杂志》 2026 (8)
1607-1619,13
国家自然科学基金资助项目(82303255).
评论